Orca-H/O/Z
Alternative Names: Orca H/O/ZLatest Information Update: 25 Nov 2022
At a glance
- Originator Orca Bio
- Class Cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Graft-versus-host disease; Haematological disorders
Most Recent Events
- 18 Oct 2022 Preclinical trials in Graft-versus-host disease in USA (Parenteral) (Orca Bio pipeline, October 2022)
- 18 Oct 2022 Preclinical trials in Haematological disorders in USA (Parenteral) (Orca Bio pipeline, October 2022)